Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in GermanyBjörn‐Erik Ole Jensen, Tom Luedde, Nadine Luebke et al.|The Lancet Regional Health - Europe|2021Cited by 117
Secondary sclerosing cholangitis as a complication of severe COVID‐19: A case report and review of the literatureCaroline Klindt, Verena Keitel, Björn‐Erik Ole Jensen et al.|Clinical Case Reports|2021Cited by 59
Rapid Selection of Sotrovimab Escape Variants in Severe Acute Respiratory Syndrome Coronavirus 2 Omicron-Infected Immunocompromised PatientsSmaranda Gliga, Björn‐Erik Ole Jensen, Nadine Lübke et al.|Clinical Infectious Diseases|2022Cited by 57
Prevalence and characterization of antimicrobial resistance among gram-negative bacteria isolated from febrile hospitalized patients in central EthiopiaTafese Beyene Tufa, Torsten Feldt, Colin R. MacKenzie et al.|Antimicrobial Resistance and Infection Control|2022Cited by 37
Acute cardiac side effects after COVID-19 mRNA vaccination: a case seriesNoemi F. Freise, Christiane Matuschek, Milena Kivel et al.|European journal of medical research|2022Cited by 23